Published: February 22, 2005

Glycology, Inc., Maker of Celsync(TM) Announces Reorganization

Share With Friends

Glycology, Inc. announced that, effective today, the Reverse Split of one share for ten shares (1 - 10) approved by the Company, as well as the name change from QuickTV, Inc. to Glycology, Inc. has now been cleared by the NASD.

The New symbol for the Company which is listed on the Pink Sheets is: GYLG

The new CUSIP number is 380000 10 9

About Glycology, Inc.

Glycology, Inc. is an innovative lifesciences company committed to commercializing new technology developed by ourselves and others.

The company's flagship product is Celsync(TM), a dietary supplement based on Nobel Prize winning molecular science.

Celsync(TM) is a true breakthrough comprised of the eight specific cell surface saccharides necessary for proper interaction between cells to boost our natural immunity. In this way, our own body's immune system can prevent cellular transfer abnormalities and defend against disease. It may even heal and improve conditions we may already have.

For more information about Glycology, Inc. or Celsync(TM), go to http://www.celsync.com/ or call 1-800-609-6517.

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: Statements in this news release looking forward in time involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, technical development risks, seasonality and other risk factors.

Distributed by Market Wire